BioSpace News Archive

Molecular genetics company MiraDx today announced it is opening patient enrollment in collaboration with UCLA for a first-ever non-tumor based microRNA biomarker-driven clinical trial for KRAS-variant positive HPV-positive head and neck cancer patients (HNSCC).

Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya” or the “Company”), has signed a $150 million USD international marketing partnership agreement with Regenerative Medicine of China, Inc. for the exclusive rights to market and sell all biological drugs developed by Zhittya during a 30-year time period.

An $8 million gift from the Foundation of Caring will help CHOC Children’s advance research for a rare lysosomal storage disease, ultimately leading to an improved understanding and more effective treatments.

Element Biosciences today announced the close of a Series B financing round of $80.3 million, with participation from new investors Fidelity Management & Research Company and JS Capital LLC, as well as existing investors Foresite Capital and Venrock.

Banner Life Sciences LLC (Banner), a privately held specialty pharmaceutical company, announced today that the U.S. District Court for the District of Delaware has ruled in favor of Banner’s motion for judgment on the pleadings against Biogen, Inc.

Global biotechnology giant CSL Limited, parent company of biotherapeutics leader CSL Behring and world-leading influenza provider Seqirus, will present at the 38th annual J.P. Morgan Healthcare Conference in San Francisco. Chief Executive Officer and Managing Director Paul Perreault will present the company’s overview on Monday, January 13,

Abilita Bio, Inc., an innovation-driven biotechnology company focused on enabling discovery and development of drugs targeting challenging membrane proteins, today announced a series of corporate updates that includes an expansion of scientific scope, personnel, and infrastructure.

The 2019 Best in KLAS for Population Health Vendor Cited by Clients for Its Strong Sense of Partnership, Collaboration and Executive Leadership

Jorjin Technologies, who started working on smart glasses when AR was still in its infancy, will be partnering with Gigabyte at this year’s CES on a joint AR-based end-to-end solution for Smart Pharmacies.

Elysium Health, Inc.™, a life sciences company developing clinically validated health products based on advancements in scientific research, today announced the initiation of a clinical trial at Duke Clinical Research Institute to study correlations between biological age and circulating NAD+ levels in healthy adults, in addition to other clinical biomarkers that have been implicated in aging.